HRT Financial’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
+107,200
| New | +$1.86M | 0.01% | 789 |
|
|
2024
Q4 | – | Sell |
-56,423
| Closed | -$1.63M | – | 2180 |
|
|
2024
Q3 | $1.63M | Buy |
+56,423
| New | +$1.63M | 0.01% | 904 |
|
|
2024
Q2 | – | Sell |
-68,575
| Closed | -$4.03M | – | 2004 |
|
|
2024
Q1 | $4.03M | Sell |
68,575
-7,337
| -10% | -$431K | 0.02% | 318 |
|
|
2023
Q4 | $4.54M | Buy |
+75,912
| New | +$4.54M | 0.03% | 316 |
|
|
2023
Q3 | – | Sell |
-309,024
| Closed | -$28.2M | – | 2138 |
|
|
2023
Q2 | $28.2M | Buy |
+309,024
| New | +$28.2M | 0.26% | 41 |
|
|
2022
Q1 | – | Sell |
-32,355
| Closed | -$1.53M | – | 2775 |
|
|
2021
Q4 | $1.53M | Buy |
+32,355
| New | +$1.53M | 0.01% | 718 |
|
|
2021
Q3 | – | Sell |
-6,204
| Closed | -$392K | – | 2971 |
|
|
2021
Q2 | $392K | Buy |
+6,204
| New | +$392K | ﹤0.01% | 1881 |
|